However, a mutation in PMS2 or MSH6 does not typically result in the concurrent loss of MLH1 or MSH2 in the tumor, likely due to PMS1 or MLH3 replacing PMS2 and MSH3 replacing MSH6 [6]. Here, PMS2 is linked to neoplasm.